MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 23 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $45,000 | 0.0% | 10,735 | 0.0% | 0.00% | – |
Q1 2019 | $45,000 | +45.2% | 10,735 | 0.0% | 0.00% | – |
Q4 2018 | $31,000 | -71.0% | 10,735 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $107,000 | +40.8% | 10,735 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $76,000 | +85.4% | 10,735 | 0.0% | 0.00% | – |
Q1 2018 | $41,000 | -53.4% | 10,735 | 0.0% | 0.00% | -100.0% |
Q4 2017 | $88,000 | +25.7% | 10,735 | -10.6% | 0.00% | 0.0% |
Q3 2017 | $70,000 | -95.9% | 12,007 | -98.7% | 0.00% | -96.8% |
Q3 2016 | $1,715,000 | +130.2% | 942,059 | +60.5% | 0.03% | +106.7% |
Q2 2016 | $745,000 | -83.9% | 586,780 | -31.7% | 0.02% | -85.4% |
Q1 2016 | $4,621,000 | -28.7% | 858,961 | +1.3% | 0.10% | -41.8% |
Q4 2015 | $6,481,000 | +185.0% | 848,236 | +211.0% | 0.18% | +185.5% |
Q3 2015 | $2,274,000 | -7.8% | 272,701 | +28.2% | 0.06% | +3.3% |
Q2 2015 | $2,467,000 | – | 212,642 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
CAXTON CORP | 61,443 | $176,000 | 0.21% |
Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |